Search Results - "Kellerman, Lior"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens by Rozales, Kinneret, Younis, Amal, Saida, Naseeb, Meller, Anatoly, Goldman, Hodaya, Kellerman, Lior, Heinrich, Ronit, Berlin, Shai, Shalgi, Reut

    Published in Nature communications (26-01-2022)
    “…Protein aggregation is a hallmark of neurodegeneration. Here, we find that Huntington’s disease-related HTT-polyQ aggregation induces a cellular proteotoxic…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The retinal toxicity profile towards assemblies of Amyloid-β indicate the predominant pathophysiological activity of oligomeric species by Naaman, Efrat, Ya’ari, Sarah, Itzkovich, Chen, Safuri, Shadi, Macsi, Flora, Kellerman, Lior, Mimouni, Michael, Mann, Irit, Gazit, Ehud, Adler-Abramovich, Lihi, Zayit-Soudry, Shiri

    Published in Scientific reports (01-12-2020)
    “…Amyloid-β (Aβ), reported as a significant constituent of drusen, was implicated in the pathophysiology of age-related macular degeneration (AMD), yet the…”
    Get full text
    Journal Article
  4. 4

    Cellular contractile forces are nonmechanosensitive by Feld, Lea, Kellerman, Lior, Mukherjee, Abhishek, Livne, Ariel, Bouchbinder, Eran, Wolfenson, Haguy

    Published in Science advances (01-04-2020)
    “…Cells' ability to apply contractile forces to their environment and to sense its mechanical properties (e.g., rigidity) are among their most fundamental…”
    Get full text
    Journal Article
  5. 5

    426. Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients by Lev, Shaul, Gottesman, Tamar, Levin, Gal Shachaf, Ber, Tahel Ilan, Angel, Alon, Kellerman, Lior, Barash, Eran, Navon, Roy, Simon, Einav, Avni, Noa, Hainrichson, Mary, Gottlieb, Tanya, Oved, Kfir, Eden, Eran, Tadmor, Boaz

    Published in Open forum infectious diseases (31-12-2020)
    “…Abstract Background It is estimated that up to 10% of SARS-CoV-2 patients progress from early and pulmonary stages to the most severe stage of illness, which…”
    Get full text
    Journal Article